Moviprep and Sucralfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) and Sucralfate (sucralfate). Common drug interactions include hysterectomy among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Moviprep and Sucralfate. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.



On Jul, 17, 2026

47 people who take Moviprep and Sucralfate together, and have interactions are studied.

Moviprep and Sucralfate drug interactions.

What are the common drug interactions of Moviprep and Sucralfate, by gender? *:

female:

  1. Hysterectomy
  2. Intraocular pressure increased
  3. Loss of consciousness
  4. Multiple fractures
  5. Muscle spasms (muscle contraction)
  6. Osteoporosis (bones weak and more likely to break)
  7. Pancreatitis (inflammation of pancreas)
  8. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  9. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  10. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Back pain
  4. Binge eating (pattern of disordered eating which consists of episodes of uncontrollable eating)
  5. Blood urine present
  6. Cardiac failure
  7. Cardiac failure congestive
  8. Cardiovascular disorder (heart diseases)
  9. Constipation
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the common drug interactions of Moviprep and Sucralfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Agitation (state of anxiety or nervous excitement)
  3. Back pain
  4. Binge eating (pattern of disordered eating which consists of episodes of uncontrollable eating)
  5. Blood urine present
  6. Constipation
  7. Cyst (a closed sac)
  8. Decreased appetite
  9. Diarrhoea
  10. Discomfort

30-39:

n/a

40-49:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease

50-59:

  1. Pain
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Death
  5. Emotional distress
  6. Multiple fractures
  7. Osteoporosis (bones weak and more likely to break)
  8. Chronic kidney disease
  9. Decreased appetite
  10. Depression

60+:

  1. Abdominal pain
  2. Constipation
  3. Drug ineffective
  4. Erythema (redness of the skin)
  5. Female genital tract fistula (passage in genital tract of female)
  6. Frequent bowel movements
  7. Haematochezia (passage of stools containing blood)
  8. Headache (pain in head)
  9. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 21 people, 44.68%
  2. Allergies: 18 people, 38.30%
  3. Colitis (inflammation of colon): 13 people, 27.66%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 12 people, 25.53%
  5. Fever: 11 people, 23.40%
  6. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 21.28%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 19.15%
  8. Pain: 9 people, 19.15%
  9. High Blood Pressure: 8 people, 17.02%
  10. High Blood Cholesterol: 6 people, 12.77%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Sucralfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Moviprep and Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Moviprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Moviprep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate and sucralfate (the active ingredients of Moviprep and Sucralfate, respectively), and Moviprep and Sucralfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: